Evidence map›Paper›PMID 40870228›Full record

ArticleMaterials (Basel, Switzerland)2025

Synthesis, Characterization, and In Vitro Cytotoxic Evaluation of Neodymium-Doped Cobalt Ferrite Nanoparticles on Human Cancer Cell Lines.

Slaviţa Rotunjanu, Armand Gogulescu, Narcisa Laura Marangoci, Andrei-Ioan Dascălu, Marius Mioc, Roxana Racoviceanu, Alexandra Mioc, Tamara Maksimović, Oana Eșanu, Gabriela Antal and 1 more

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Early ADME and Preliminary Toxicity Studies of I-152, anChemical research in toxicology · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Slaviţa RotunjanuFaculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Armand GogulescuFaculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.ORCID 0009-0004-4301-2279
Narcisa Laura MarangociInstitute of Macromolecular Chemistry 'Petru Poni', 700487 Iasi, Romania.ORCID 0000-0002-6629-6460
Andrei-Ioan DascăluInstitute of Macromolecular Chemistry 'Petru Poni', 700487 Iasi, Romania.ORCID 0000-0002-0715-6855
Marius MiocFaculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Roxana RacoviceanuFaculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.ORCID 0000-0002-3378-0774
Alexandra MiocFaculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Tamara MaksimovićFaculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Oana EșanuFaculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Gabriela AntalFaculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Codruţa ȘoicaFaculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Funding

Ministerul Cercetării și Inovării CNCS/CCCDI - UEFISCDI, PN-IV-P8-8.1-PRE-HE-ORG-2023-0048Romanian National Authority for Scientific Research UEFISCDI PN-IV-P2-2.1-TE-2023-1790Victor Babeș University of Medicine and Pharmacy Timișoara
6 · The paper itself

Abstract

Cancer is still the world's most prevalent cause of death, and the limited efficacy of current treatments highlights the requirement for new therapeutic approaches. In this study, neodymium (Nd)-doped cobalt ferrite (CoFe

Indexed as

anticancercell viabilitycobalt ferritescytotoxicityneodymium-doped magnetic nanoparticles

Identifiers

PMID40870228
PMCPMC12387337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.